missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies Reversine

Adenosine receptor, non-muscle myosin II (NM II), MEK1, and aurora kinase inhibitor

1466.10 SEK - 4257.90 SEK

Specifications

CAS 656820-32-5
Molecular Formula C21H27N7O
Purity >98%
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17160092
Encompass_Preferred
View Documents
STEMCELL Technologies
72612
1 mg
1466.10 SEK
1mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
17170092
Encompass_Preferred
View Documents
STEMCELL Technologies
72614
5 mg
4257.90 SEK
5mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

  • Reversine is a 2,6-disubstituted purine derivative that inhibits the human A3 adenosine receptor, nonmuscle myosin II heavy chain, mitogen activated extracellular signal regulated kinase-1 (MEK1), and Aurora B kinase (Chen et al.; Perreira et al.; D'Alise et al.)
Specifications

Specifications

656820-32-5
C21H27N7O
>98%
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.